PGDip in Pharmaceutical Business and Technology
This Springboard funded course is flexibly designed to suit the needs of those in employment. Lectures are a blend of online, distance and 2 Saturdays per month in Dublin or Cork.
The PGDip Pharmaceutical Business & Technology is suited to those from a science, engineering or quality disciplines to learn about the processes of pharmaceuticals and their production, as well as infusing your knowledge of the business and technological sides of the sector. This will help give you an extra edge in your qualifications. In addition, you’ll be awarded insights into the newly emerging trends in the industry, along with classes in leadership development and strengthening your professional skills.
With extensive input and participation from the pharmaceutical and clinical trials sectors, this programme is ideal for those involved in manufacturing, compliance, business improvement, quality assurance, validation, data analytics, clinical trial coordination and engineering.
All of our courses are designed to the highest industry standards. Extensive coaching and mentoring workshops will be provided with a specific focus on individual assessment and improvement. We have the very best of tutors and encourage them to actively engage with our students so you get the support you need whilst studying.
All classes are broadcast live using an online training platform, offering the learners the opportunity to either physically attend or join the class online. All classes are recorded also allowing learners the opportunity to view later and support revision. Students are required to attend the campus on two Saturdays a month.
Why up-skill for the pharmaceutical industry in Ireland?
- €3 billion in new capital investment
- €39 billion in exports
- Over 55,000 employed
- 9 of top 10 world’s biopharma companies in Ireland
- 12 of the top-selling drugs made in Ireland
- Over 8,000 new jobs predicted by 2020
Our graduates are now working in leading pharma and medtech companies in Ireland including the following: